Norditropin Injection, Solution
Product Images NDC 0169-7705

134 FDA label images from Novo Nordisk · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 134 technical images submitted to the FDA as part of the official labeling for Norditropin (NDC 0169-7705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

5mg-overview (Image 05)

5mg-overview (Image 05)
Norditropin 30 mg/3 mL injection solution carton, labeled for subcutaneous use. The packaging is primarily yellow and white with the Novo Nordisk logo at the top. The product name Norditropin and the strength 30 mg/3 mL are clearly visible along with the labeler Novo Nordisk. This is a human prescription drug solution for injection.*
FDA Label Image

5mg-needle-ex (Image 06)

5mg-needle-ex (Image 06)
An instructional illustration showing a green Norditropin injection pen next to a medicine vial and a separate needle. The pen is labeled for subcutaneous injection, representing the product Norditropin (somatropin) in injection solution form by Novo Nordisk.*
FDA Label Image

5mg-supplies (Image 07)

5mg-supplies (Image 07)
Instructional diagram depicting a close-up of a hand holding a Norditropin injection pen. The pen tip is shown with the cap being removed or attached, illustrating part of the medication preparation process for the subcutaneous injection of somatropin.*
FDA Label Image

5mg-a (Image 08)

5mg-a (Image 08)
An instructional illustration showing components of the PenMate device for Norditropin somatropin injection. It highlights the charm slot, PenMate cap, PenMate window, and insertion button on the injection device used for subcutaneous administration.*
FDA Label Image

5mg-b (Image 09)

5mg-b (Image 09)
Illustration of the Norditropin FlexPro 5 mg, 10 mg, or 15 mg injection pen showing labeled parts including pen cap, front stopper, growth hormone scale, needle thread, pen window, display window, dose pointer, dose selector, and dose button.*
FDA Label Image

5mg-c (Image 10)

5mg-c (Image 10)
An illustration of a blue pen case for Norditropin injection solution. The case is shown open, designed to hold and protect the pen for subcutaneous injection of somatropin. Text below the image indicates that the pen and needles are not included in the case.*
FDA Label Image

5mg-d (Image 11)

5mg-d (Image 11)
An instructional illustration showing a close-up of hands removing a protective cap from the needle of a subcutaneous injection device. An arrow indicates the direction of cap removal, demonstrating how to prepare the injection for use.*
FDA Label Image

5mg-e (Image 12)

5mg-e (Image 12)
An instructional diagram showing a hand holding a device, with an arrow indicating the direction to slide or pull a component, likely related to preparing or administering the Norditropin injection solution.*
FDA Label Image

5mg-f (Image 13)

5mg-f (Image 13)
An instructional illustration showing a hand holding a pen-like device with a cap being removed by pulling it away, indicated by an arrow. This is part of the usage instructions for the Norditropin injection solution delivery device.*
FDA Label Image

5mg-g (Image 14)

5mg-g (Image 14)
An instructional diagram showing two hands adjusting the dosage setting on a Norditropin injection pen. The image highlights a dose window indicating a specific milligram amount, demonstrating how to select or confirm the dose before subcutaneous injection.*
FDA Label Image

5mg-h (Image 15)

5mg-h (Image 15)
Illustration showing a close-up of the dosage window on an injection pen for Norditropin (somatropin) solution. The dial displays a dosage setting between 0.2 and 0 mg, indicating the pen's adjustable dose feature for subcutaneous injection.*
FDA Label Image

5mg-i (Image 16)

5mg-i (Image 16)
An instructional illustration showing a hand holding the Norditropin injection device, with a directional arrow pointing upward, indicating a step to remove or adjust a part of the device. The image is related to the preparation or administration of the Norditropin subcutaneous injection.*
FDA Label Image

5mg-j (Image 17)

5mg-j (Image 17)
An instructional illustration showing the tip of an injection pen with a droplet at the needle end. The image is associated with Norditropin (somatropin) injection, solution for subcutaneous use, by Novo Nordisk.*
FDA Label Image

5mg-k (Image 18)

5mg-k (Image 18)
Illustration showing a close-up view of a dosage selection window on a Norditropin injection pen, highlighting the 0.35 mg dose setting as an example of subcutaneous somatropin administration.*
FDA Label Image

5mg-l (Image 19)

5mg-l (Image 19)
An instructional illustration showing hands adjusting or preparing a Norditropin injection pen. The image highlights the dosage window on the pen, displaying a dose setting of 1.35 mg. The illustration focuses on proper grip and dose selection on the subcutaneous injection device for somatropin solution.*
FDA Label Image

5mg-m (Image 20)

5mg-m (Image 20)
An instructional illustration showing the correct subcutaneous injection technique using a Norditropin injection pen. The image depicts a hand holding the injection pen vertically with the needle pointing downward toward the skin, indicating the angle and position for proper administration.*
FDA Label Image

5mg-n (Image 21)

5mg-n (Image 21)
An instructional illustration showing a hand holding a Norditropin injection pen with an arrow indicating downward pressure, demonstrating how to administer a subcutaneous injection. A dose window on the pen displays the dosage amount, emphasizing precise dosing.*
FDA Label Image

5mg-o (Image 22)

5mg-o (Image 22)
An instructional illustration depicting a hand holding an injection pen for Norditropin (somatropin) with a focus on slowly counting "1-2-3-4-5-6" while the pen is pressed against the skin, indicating a step in administering the subcutaneous injection.*
FDA Label Image

Image-p (Image 23)

Image-p (Image 23)
An instructional illustration showing a subcutaneous injection technique with the Norditropin pen. The image depicts the injection device positioned at the injection site with an upward arrow, indicating the direction to pull or position for the injection process.*
FDA Label Image

5mg-q (Image 24)

5mg-q (Image 24)
Instructional illustration showing a hand twisting and removing the protective cap from the needle of a Norditropin injection pen before use, indicating preparation for subcutaneous administration.*
FDA Label Image

5mg-r (Image 25)

5mg-r (Image 25)
An instructional illustration showing a vial with a cap and an arrow indicating removal of the cap. This likely represents how to open the vial before use.*
FDA Label Image

5mg-s (Image 26)

5mg-s (Image 26)
An instructional diagram showing a close-up of hands demonstrating the use of a pen injector device, likely for Norditropin injection solution. The illustration includes an arrow indicating the connection or assembly step of the orange and blue parts of the pen.*
FDA Label Image

5mg-t (Image 27)

5mg-t (Image 27)
An instructional illustration showing the dose scale on a Norditropin somatropin injection pen. The pen scale is labeled with numbers 1, 2, and 3, indicating dosage amounts, alongside an example annotation indicating approximately 2 mg dose remaining in the pen.*
FDA Label Image

5mg-u (Image 28)

5mg-u (Image 28)
An instructional illustration showing a hand holding a Norditropin injection pen, focusing on the dose display, which reads 1.25 mg, demonstrating how to read the remaining dose amount on the pen's dose window.*
FDA Label Image

Phone-qrcode (Image 29)

Phone-qrcode (Image 29)
Instructional image showing a smartphone with an arrow pointing outward toward a QR code on the right, suggesting scanning the QR code using the phone.*
FDA Label Image

10mg-overview (10mg Overview)

10mg-overview (10mg Overview)
Illustration of the Norditropin FlexPro Pen, a prefilled injection device for somatropin 10 mg/1.5 mL. The diagram labels key parts including the pen window, pen scale, dose counter, dose pointer, dose selector, dose button, and pen cap. The pen is designed for subcutaneous use.*
FDA Label Image

10mg-example (10mg Example)

10mg-example (10mg Example)
An instructional illustration showing components of a needle used for injection. The labeled parts include outer needle cap, inner needle cap, needle itself, and a paper tab. The diagram visually supports correct identification and handling of needle parts for injection.*
FDA Label Image

10mg-supplies (10mg Supplies)

10mg-supplies (10mg Supplies)
Illustration showing a Norditropin injection pen with a cap removed, a small attachment piece, and a medicine bottle. This depicts the components used for subcutaneous injection of Norditropin (somatropin), a human prescription drug by Novo Nordisk.*
FDA Label Image

10mg-a (10mg A)

10mg-a (10mg A)
An instructional illustration showing a hand holding a pen-style injectable device, likely demonstrating how to hold or prepare the device for subcutaneous injection. The device is predominantly teal and white with a blue cap on one end.*
FDA Label Image

10mg-b (10mg B)

10mg-b (10mg B)
An instructional illustration showing a hand removing a protective cap from the needle of a Norditropin somatropin injection pen. The image highlights the proper technique for preparing the subcutaneous injection device before use.*
FDA Label Image

10mg-c (10mg C)

10mg-c (10mg C)
An instructional illustration showing a hand gripping and preparing to attach or remove a cap from a medical device or pen, likely related to the administration of Norditropin injection solution. The image emphasizes hand positioning and directional movement indicated by a bold arrow pointing left.*
FDA Label Image

10mg-d (10mg D)

10mg-d (10mg D)
Instructional illustration showing a hand removing a small cap or seal from the tip of a syringe or injection pen. An arrow indicates the direction of removal. The image is a step in preparing an injection, likely related to the Norditropin somatropin injection solution.*
FDA Label Image

10mg-e (10mg E)

10mg-e (10mg E)
An instructional illustration showing hands adjusting the dose on a Norditropin somatropin injection pen. The image depicts rotating the dose selector with an arrow indicating the direction of adjustment.*
FDA Label Image

10mg-f (10mg F)

10mg-f (10mg F)
An illustration showing the dose selection window on a Norditropin injection pen. The window displays a dose setting between 0 and 0.1 mg, indicating the adjustable dosage for subcutaneous administration of the somatropin solution.*
FDA Label Image

10mg-g (10mg G)

10mg-g (10mg G)
Illustration showing a hand holding a Norditropin injection pen cartridge, with an arrow pointing upward indicating the direction to pull or remove the cartridge cap or protective cover. The image is designed to guide users in preparing the subcutaneous injection.*
FDA Label Image

10mg-h (10mg H)

10mg-h (10mg H)
An instructional illustration showing a close-up of a syringe needle dispensing a drop of liquid at the tip. The image likely relates to subcutaneous injection technique for a medication like Norditropin (somatropin).*
FDA Label Image

10mg-i (10mg I)

10mg-i (10mg I)
An instructional illustration showing a person holding a Norditropin injection pen. The image demonstrates how to adjust or set the dosage by turning a dial on the pen, with an arrow indicating the direction to turn. The illustration focuses on proper handling of the somatropin injection device.*
FDA Label Image

10mg-j (10mg J)

10mg-j (10mg J)
An illustration showing a close-up view of a dosing dial on a Norditropin injection pen, displaying a dose selection between 2.9 mg and 3.0 mg. The example indicates a dose of 2.95 mg selected. The image demonstrates how to read or set the dosage on the device.*
FDA Label Image

10mg-k (10mg K)

10mg-k (10mg K)
An instructional diagram showing a dose selector window on a Norditropin injection pen, indicating a selected dose of 0.7 mg. The image highlights the numerical dose display for subcutaneous somatropin injection adjustment.*
FDA Label Image

10mg-l (10mg L)

10mg-l (10mg L)
Illustration shows a person adjusting the dose on the Norditropin injection pen by turning the dose selector dial. The digital display on the pen indicates the set dose in milligrams, demonstrating how to prepare the pen for subcutaneous injection.*
FDA Label Image

10mg-m (10mg M)

10mg-m (10mg M)
An instructional illustration showing a hand holding an injection pen, likely for subcutaneous use, with a downward arrow indicating the direction of injection or action to be performed.*
FDA Label Image

10mg-n (10mg N)

10mg-n (10mg N)
Instructional illustration showing a hand holding a Norditropin injection pen vertically with an arrow pointing downward, indicating the proper technique for subcutaneous injection. A close-up of the dosage display on the pen shows '0 mg.'*
FDA Label Image

10mg-o (10mg O)

10mg-o (10mg O)
An instructional illustration showing a hand holding a Norditropin injection pen at a right angle to the forearm. A speech bubble instructs to count slowly from 1 to 6 while administering the injection subcutaneously. The image visually guides on the injection technique for Norditropin somatropin solution.*
FDA Label Image

10mg-p (10mg P)

10mg-p (10mg P)
An instructional illustration showing a close-up of a pen-injector device with a needle at the bottom. An upward arrow beside the pen indicates the direction to pull or remove the needle cap or cover. The image focuses on the pen tip and needle area, relevant for subcutaneous injection preparation.*
FDA Label Image

10mg-q (10mg Q)

10mg-q (10mg Q)
An instructional illustration showing a hand twisting off a protective cap from the tip of a Norditropin injection pen, indicating preparation for subcutaneous injection.*
FDA Label Image

10mg-r (10mg R)

10mg-r (10mg R)
An instructional illustration showing a vial with a removable cap being lifted off. The arrow points upward from the vial cap, indicating removal or opening of the vial.*
FDA Label Image

10mg-s (10mg S)

10mg-s (10mg S)
An instructional illustration showing a hand holding and demonstrating the removal of a cap from a pen-style injector device. The image includes an arrow indicating the direction to pull the cap off, which is typical for preparing an injection pen for use.*
FDA Label Image

10mg-t (10mg T)

10mg-t (10mg T)
An instructional illustration showing the dose scale on a Norditropin pen injector. The pen scale is marked from 2 to 6, with a note indicating an example of approximately 4 mg remaining in the pen.*
FDA Label Image

10mg-u (10mg U)

10mg-u (10mg U)
An instructional illustration depicting a hand adjusting a dial on a Norditropin somatropin injection pen to select a dose. The close-up inset shows the dose window displaying 2.4 mg left as an example. The image guides proper dose setting for subcutaneous injection.*
FDA Label Image

Phone-qrcode.jpg (Phone Qrcode)

FDA Label Image

15mg-overview (15mg Overview)

15mg-overview (15mg Overview)
Illustration of the Norditropin FlexPro Pen injection device labeled with its components: pen cap, pen window, pen scale, dose counter, dose pointer, dose selector, and dose button. The pen is shown with a 15 mg/1.5 mL strength label and indicated for subcutaneous use.*
FDA Label Image

15mg-example (15mg Example)

15mg-example (15mg Example)
An instructional diagram showing components of a needle for injection, including an outer needle cap, inner needle cap, the needle itself, and a paper tab. This is related to Norditropin (somatropin) injection, solution for subcutaneous use by Novo Nordisk.*
FDA Label Image

15mg-supplies (15mg Supplies)

15mg-supplies (15mg Supplies)
An illustration showing a Norditropin injection pen with a green handle and blue cap, alongside an empty vial with a gray cap and a small detachable needle tip. This depicts components used for subcutaneous injection of somatropin solution.*
FDA Label Image

15mg-a (15mg A)

15mg-a (15mg A)
Illustration showing a hand holding the tip of a Norditropin injection pen used for subcutaneous administration of somatropin. The image highlights the green-colored needle or cap area of the injection device.*
FDA Label Image

15mg-b (15mg B)

15mg-b (15mg B)
Instructional illustration showing a hand operating a Norditropin injection pen by pulling off the pen needle cap, indicated by an arrow. The image highlights the process of preparing the Norditropin subcutaneous injection solution for use.*
FDA Label Image

15mg-c (15mg C)

15mg-c (15mg C)
An instructional illustration showing a hand holding a vial or cartridge with an arrow indicating alignment or insertion action. The image appears to demonstrate how to connect or prepare a device for injection, likely related to Norditropin somatropin injection solution.*
FDA Label Image

15mg-d (15mg D)

15mg-d (15mg D)
An instructional illustration showing a hand holding a pen-like device with a removable cap or cover being pulled off. The image appears to demonstrate how to remove the cap from the injection device for Norditropin, a subcutaneous injection solution of somatropin.*
FDA Label Image

15mg-e (15mg E)

15mg-e (15mg E)
Illustration showing a close-up of hands adjusting the dosage setting on a Norditropin somatropin injection pen. The image focuses on the dose window and dose adjustment mechanism of the subcutaneous injection device.*
FDA Label Image

15mg-f (15mg F)

15mg-f (15mg F)
An illustration showing a close-up view of a dosage dial indicator labeled with "mg" units, used for adjusting the dose on a Norditropin injection pen. The dial window displays numeric measurement markings for precise dosing of somatropin solution.*
FDA Label Image

15mg-g (15mg G)

15mg-g (15mg G)
An instructional illustration showing a hand holding a Norditropin injection pen. The hand grips the pen at the top while an arrow points upward from the bottom green cap, indicating the direction to remove or pull off the pen cap before use.*
FDA Label Image

15mg-h (15mg H)

15mg-h (15mg H)
Illustration showing a close-up view of the tip of a Norditropin injection pen with a needle attached, depicting a drop of liquid at the needle's end. The image highlights the injection device used for subcutaneous administration of Norditropin (somatropin) solution.*
FDA Label Image

15mg-i (15mg I)

15mg-i (15mg I)
An instructional illustration showing two hands adjusting the dose on a Norditropin injection device. The image highlights the dial mechanism used for setting the somatropin dosage before subcutaneous injection.*
FDA Label Image

15mg-j (15mg J)

15mg-j (15mg J)
An illustration showing a close-up view of a dosage selection window on a Norditropin injection device. The window displays doses between 5.8 mg and 6.0 mg, with a note example indicating a 5.9 mg dose selected. This demonstrates how to read the dosage dial on the pen for subcutaneous injection.*
FDA Label Image

15mg-k (15mg K)

15mg-k (15mg K)
An illustration showing a dose selector dial on a Norditropin injection pen, highlighting a selected dose of 1.2 mg. The dial numbers range from 1.0 to 1.4 mg, indicating adjustable dosing for subcutaneous injection of somatropin.*
FDA Label Image

15mg-l (15mg L)

15mg-l (15mg L)
An instructional illustration showing hands adjusting a dosing dial on a Norditropin injection pen. The display window on the pen shows a dose setting of 12 mg, with an arrow indicating the mechanism to turn or set the dose for subcutaneous injection.*
FDA Label Image

15mg-m (15mg M)

15mg-m (15mg M)
Illustration showing a hand holding a pen-like injection device vertically, with a downward arrow indicating the direction to press or insert. This likely demonstrates part of the administration technique for Norditropin somatropin injection solution by subcutaneous route.*
FDA Label Image

15mg-n (15mg N)

15mg-n (15mg N)
An instructional illustration showing a hand holding a Norditropin injection pen with an arrow pointing downward, indicating the direction for injection. The pen's dosage window displays 0.3 mg. This diagram relates to the subcutaneous injection of Norditropin (somatropin) human prescription drug in solution form.*
FDA Label Image

15mg-o (15mg O)

15mg-o (15mg O)
An instructional illustration showing a hand holding a pen-style injector for subcutaneous injection on an arm. The image includes a speech bubble instructing to count slowly from 1 to 6, indicating timing for injection.*
FDA Label Image

15mg-p (15mg P)

15mg-p (15mg P)
Instructional illustration showing a green and blue injection pen with a needle attached, positioned above a surface. An upward arrow indicates the motion to pull or remove the needle cap, demonstrating preparation for subcutaneous injection.*
FDA Label Image

15mg-q (15mg Q)

15mg-q (15mg Q)
An instructional illustration showing a hand twisting off the cap of a pen injector device, indicated by a curved arrow. The device likely corresponds to Norditropin injection, solution, used for subcutaneous administration.*
FDA Label Image

15mg-r (15mg R)

15mg-r (15mg R)
An instructional illustration showing a vial with a screw cap and an arrow indicating the direction to open the cap, accompanied by a small depiction of a syringe or needle, suggesting preparation or injection steps for medication.*
FDA Label Image

15mg-s (15mg S)

15mg-s (15mg S)
An instructional illustration showing hands manipulating a green and blue pen injector device, likely demonstrating how to prepare or operate the device for injection.*
FDA Label Image

15mg-t (15mg T)

15mg-t (15mg T)
An instructional diagram showing the dosage window of a Norditropin somatropin injection pen, indicating the approximate amount of medication left (e.g., 6 mg) and the pen scale markings for dosing.*
FDA Label Image

15mg-u (15mg U)

15mg-u (15mg U)
An instructional illustration showing a hand holding and dialing a dose on a Norditropin injection pen, highlighting the dose display window with an example dose of 3.8 mg left to administer. The image demonstrates how to read the remaining dose before injection.*
FDA Label Image

15mg-phone-qrcode (15mg Phone Qrcode)

FDA Label Image

30mg-overview (30mg Overview)

30mg-overview (30mg Overview)
Illustration of the Norditropin FlexPro Pen prefilled injection device showing labeled parts including the pen window, pen scale, dose counter, dose pointer, dose selector, dose button, and pen cap. The pen contains Norditropin (somatropin) 30 mg/3 mL for subcutaneous use.*
FDA Label Image

30mg-needle-example (30mg Needle Example)

30mg-needle-example (30mg Needle Example)
An instructional illustration showing examples of components related to a needle: an outer needle cap, inner needle cap, the needle itself, and a paper tab. Each part is labeled clearly for identification.*
FDA Label Image

30mg-supplies (30mg Supplies)

30mg-supplies (30mg Supplies)
An instructional illustration showing a Norditropin injection pen, a vial with a screw cap, and a small removable component, likely part of the injection pen assembly. The items are depicted on a light background, with the Norditropin pen labeled, used for subcutaneous injection of somatropin solution.*
FDA Label Image

30mg-a (30mg A)

30mg-a (30mg A)
Illustration showing a close-up of a hand holding a Norditropin injection pen cartridge, highlighting the action of preparing the cartridge for subcutaneous injection. The pen cartridge appears purple and is designed for use with the Norditropin somatropin injection solution.*
FDA Label Image

30mg-b (30mg B)

30mg-b (30mg B)
An instructional illustration showing a hand removing a cap or cover from a syringe or pen injector, likely related to the preparation or use of an injectable medication such as Norditropin (somatropin). The image depicts the steps involved in handling the injection device prior to administration.*
FDA Label Image

30mg-c (30mg C)

30mg-c (30mg C)
An instructional illustration showing a hand gripping a pen-like device, with an arrow indicating a twisting or turning motion. This likely demonstrates how to prepare or use the Norditropin somatropin injection pen for subcutaneous administration.*
FDA Label Image

30mg-d (30mg D)

30mg-d (30mg D)
An instructional illustration showing a hand holding and attaching a needle to a Norditropin injection pen for subcutaneous use. The image indicates the proper way to connect the needle to the pen by pushing it straight on, represented by an arrow pointing inward.*
FDA Label Image

30mg-e (30mg E)

30mg-e (30mg E)
Instructional illustration showing the use of a Norditropin somatropin injection pen. The image depicts hands unlocking or preparing the injection pen by turning or lifting a component, indicated by an arrow. The pen has a visible dosage display window.*
FDA Label Image

30mg-f (30mg F)

30mg-f (30mg F)
Illustration of a dosage window on a Norditropin somatropin injection pen showing a dialed dose setting at 0.2 mg.*
FDA Label Image

30mg-g (30mg G)

30mg-g (30mg G)
An instructional illustration showing a hand holding a Norditropin injection pen, with an arrow indicating an upward motion. The image likely demonstrates how to remove or adjust a component of the injection device prior to use.*
FDA Label Image

30mg-h (30mg H)

30mg-h (30mg H)
An illustration showing a close-up view of a subcutaneous injection needle with a droplet at the tip, indicating preparation or administration of an injectable solution.*
FDA Label Image

30mg-i (30mg I)

30mg-i (30mg I)
An instructional illustration showing hands adjusting the dosage dial on a Norditropin somatropin subcutaneous injection device. The image highlights setting the desired dose on the pen injector prior to administration.*
FDA Label Image

30mg-j (30mg J)

30mg-j (30mg J)
An illustration showing a dosage selector on a Norditropin injection pen. The dose window displays a selected dose of 2.4 mg. The example highlights how the dose is indicated on the pen's scale for subcutaneous injection of somatropin.*
FDA Label Image

30mg-k (30mg K)

30mg-k (30mg K)
An instructional illustration showing a dosing window on a Norditropin injection pen, highlighting a selected dose of 0.7 mg with visible markings at 0.6 mg and 0.8 mg. The example text below clarifies the selected dose as 0.7 mg.*
FDA Label Image

30mg-l (30mg L)

30mg-l (30mg L)
An instructional illustration showing the use of a Norditropin pen injector, displaying a close-up of hands holding the device and adjusting the dosage dial to set 2.4 mg before injection. The image emphasizes dosage selection and proper device handling for somatropin subcutaneous injection.*
FDA Label Image

30mg-m (30mg M)

30mg-m (30mg M)
An instructional illustration showing a hand holding a syringe-like injection device in a vertical position with the thumb pressing down. A downward arrow indicates the direction of injection subcutaneously into the skin. This image demonstrates the proper technique for administering a subcutaneous injection, likely related to the Norditropin somatropin injection.*
FDA Label Image

30mg-n (30mg N)

30mg-n (30mg N)
Instructional illustration showing a hand holding a Norditropin injection pen with an arrow pointing downward, indicating the direction to press or inject. A close-up inset shows the dosage display on the pen set to 0.2 mg.*
FDA Label Image

30mg-o. (30mg O)

30mg-o. (30mg O)
An instructional illustration showing a hand holding a syringe against a forearm with a speech bubble advising to count slowly from one to six during injection. This likely demonstrates part of the administration technique for Norditropin injection solution.*
FDA Label Image

30mg-p (30mg P)

30mg-p (30mg P)
An instructional illustration showing a subcutaneous injection technique with a needle approaching the skin at an angle. The image includes an upward arrow indicating the direction of needle withdrawal from the injection site. It is likely associated with Norditropin (somatropin) subcutaneous injection guidance.*
FDA Label Image

30mg-q (30mg Q)

30mg-q (30mg Q)
Illustration showing the step to peel off a protective cap from a needle used with the Norditropin somatropin injection pen before subcutaneous injection.*
FDA Label Image

30mg-r (30mg R)

30mg-r (30mg R)
Instructional diagram showing the removal of a cap from a bottle, with an arrow indicating the upward movement of the cap to open the container.*
FDA Label Image

30mg-s (30mg S)

30mg-s (30mg S)
An instructional illustration showing a close-up of hands assembling or preparing a pen-style injection device, likely related to Norditropin somatropin solution for subcutaneous injection. The image focuses on aligning or connecting two parts of the device, indicated by a directional arrow.*
FDA Label Image

30mg-t (30mg T)

30mg-t (30mg T)
An instructional diagram showing a close-up view of a Norditropin injection pen scale with the pen's dosage window indicating approximately 10 mg left. Annotations label the pen scale and highlight the example dosage amount visible on the pen.*
FDA Label Image

30mg-u (30mg U)

30mg-u (30mg U)
An instructional illustration showing a person adjusting the dosage setting on a Norditropin injection device. The close-up highlights the dose dial indicating 3.8 mg left, with an arrow guiding how to change the dose.*
FDA Label Image

30mg-phoneqrcode (30mg Phoneqrcode)

FDA Label Image

Fig-a.jpg (Fig A)

Fig-a.jpg (Fig A)
Illustration of the PenMate accessory device for Norditropin somatropin injection, showing its components including the PenMate cap with charm slot, PenMate window, and insertion button. The diagram depicts the device in different orientations to highlight these features.*
FDA Label Image

Fig-b (Fig B)

Fig-b (Fig B)
An instructional diagram of the Norditropin injection pen for subcutaneous delivery of somatropin. The pen features labeled parts including the pen cap, front stopper, needle thread, growth hormone scale, pen window, display window, dose pointer, dose selector, and dose button, illustrating the components used to prepare and administer the dose.*
FDA Label Image

Fig-c (Fig C)

Fig-c (Fig C)
An instructional illustration showing parts and supplies related to needle use, including an outer needle cap, inner needle cap, needle (up to 8 mm length), paper tab, alcohol swabs, and a sharps disposal container. This diagram supports safe handling and disposal guidance for injection needles.*
FDA Label Image

Fig-d (Fig D)

Fig-d (Fig D)
An illustration showing an open blue pen case designed to hold a medication pen. The case is shown empty except for an inset compartment, with text indicating that pen and needles are not included in the case. The image likely relates to Norditropin somatropin injection pen storage accessories.*
FDA Label Image

Fig-e (Fig E)

Fig-e (Fig E)
An instructional illustration labeled 'PenMate cap Figure E' showing a close-up of hands removing or attaching a blue PenMate cap, indicated by an arrow pointing to the left. The illustration likely relates to handling the Norditropin injection pen device.*
FDA Label Image

Fig-f (Fig F)

Fig-f (Fig F)
An instructional illustration showing a close-up of hands removing the pen cap from a Norditropin injection pen. The image focuses on the proper grip and direction to pull the cap off, aiding in the correct preparation of the somatropin subcutaneous injection.*
FDA Label Image

Fig-g (Fig G)

Fig-g (Fig G)
An instructional illustration labeled as Figure G showing a hand holding a Norditropin pen injector. The orange pen window of the device is clearly visible, highlighting part of the injection mechanism for the somatropin injection solution.*
FDA Label Image

Fig-h (Fig H)

Fig-h (Fig H)
An instructional diagram labeled Figure H illustrating the preparation step involving the front stopper of an injection device. It shows a hand holding a wipe or cloth near the front stopper of a pen-like device, indicating a cleaning or sterilization action likely related to Norditropin injection administration.*
FDA Label Image

Fig-i (Fig I)

Fig-i (Fig I)
An instructional illustration showing a hand pressing the insertion button on a Norditropin injection device. The display window on the device is also labeled, highlighting key parts for administering the somatropin injection subcutaneously.*
FDA Label Image

Fig-j (Fig J)

Fig-j (Fig J)
Instructional illustration showing hands peeling away a paper tab from a medication device or packaging, labeled as Figure J. This diagram likely demonstrates a step in preparing the product for use.*
FDA Label Image

Fig-k (Fig K)

Fig-k (Fig K)
An instructional illustration showing two hands holding a Norditropin injection pen. One hand is gripping the pen while the other is adjusting a dial or control at the end of the device, indicated by a circular arrow, to set or change the injection dose.*
FDA Label Image

Fig-l (Fig L)

Fig-l (Fig L)
Illustration labeled Figure L showing the removal of an outer needle cap from an injection device. The image depicts a hand pulling the outer needle cap straight off the needle, indicating a step in the preparation of a subcutaneous injection.*
FDA Label Image

Fig-m (Fig M)

Fig-m (Fig M)
Illustration labeled Figure M showing a hand removing the inner needle cap from an injection pen device. The image depicts the action of pulling the inner needle cap away from the pen, indicated by an arrow.*
FDA Label Image

Fig-n (Fig N)

Fig-n (Fig N)
An instructional illustration depicting the dose selector mechanism of a Norditropin injection pen device. It shows a hand adjusting the dose selector to set the desired dose, with a close-up view of the dosage indicator displaying 0.15 mg.*
FDA Label Image

Fig-o (Fig O)

Fig-o (Fig O)
An instructional diagram showing Norditropin and Sogroya injection pen color codes by strength (5 mg, 10 mg, 15 mg) and corresponding minimum and maximum dose ranges. Each strength pairs a Norditropin pen color with a Sogroya pen color and displays dosing increments on circular dose indicators.*
FDA Label Image

Fig-p (Fig P)

Fig-p (Fig P)
An instructional diagram showing a hand pressing a button or knob on a Norditropin injection device. The device appears to have a window or indicator that signals activation, depicted by motion lines around the window area.*
FDA Label Image

Fig-q (Fig Q)

Fig-q (Fig Q)
An instructional illustration showing how to use the Norditropin injection device. It highlights pressing the dose button to release a drop of liquid, demonstrating the subcutaneous injection process for somatropin solution.*
FDA Label Image

Fig-r (Fig R)

Fig-r (Fig R)
An instructional illustration titled 'Dose selector Figure R' showing a close-up of a hand adjusting the dose selector on an injection pen device. The image emphasizes the rotation motion used to set the dosage in milligrams for administering Norditropin (somatropin) injection solution.*
FDA Label Image

Fig-s (Fig S)

Fig-s (Fig S)
An anatomical illustration showing front and back views of a human figure with shaded areas indicating common subcutaneous injection sites, including abdomen, thighs, and upper arms."*
FDA Label Image

Fig-t (Fig T)

Fig-t (Fig T)
An instructional illustration showing a hand operating a Norditropin injection pen. It highlights the locations of the insertion button on the PenMate device and the dose button on the pen itself, labeled as Figure T.*
FDA Label Image

Fig-u (Fig U)

Fig-u (Fig U)
An instructional illustration showing a hand holding a Norditropin injection pen with a close-up of the insertion button. The diagram highlights the button used to administer the subcutaneous injection of somatropin solution.*
FDA Label Image

Fig-v (Fig V)

Fig-v (Fig V)
An instructional illustration showing a hand holding a Norditropin injection pen. The diagram highlights pressing the dose button with an arrow pointing downward, accompanied by a clock symbol indicating to hold for 6 seconds. This demonstrates the proper technique for administering the subcutaneous injection.*
FDA Label Image

Fig-w (Fig W)

Fig-w (Fig W)
An instructional illustration showing a close-up of an injection device, specifically the lower portion where the needle or injection mechanism is located. A blue arrow pointing upward indicates the direction to pull or remove a part from the device, likely related to use or preparation of the Norditropin somatropin injection solution.*
FDA Label Image

Fig-x (Fig X)

Fig-x (Fig X)
Instructional illustration showing the removal of an outer needle cap from a medical injection device by hand. The image depicts a close-up of the device's needle end with an arrow indicating the direction to pull the cap off.*
FDA Label Image

Fig-y (Fig Y)

Fig-y (Fig Y)
Illustration showing a hand using a device, possibly an injection pen, with a finger peeling or pulling away a protective cover or seal from the device tip, indicating a step in product preparation or administration, associated with Norditropin injection solution.*
FDA Label Image

Fig-z (Fig Z)

Fig-z (Fig Z)
An instructional illustration showing a person removing a cap from a Norditropin somatropin injection pen by gripping the pen and pulling the cap away. The diagram is circular with a blue and beige color scheme, demonstrating proper handling of the subcutaneous injection device.*
FDA Label Image

Fig-aa (Fig Aa)

Fig-aa (Fig Aa)
An instructional illustration showing how to rotate the dose knob on a Norditropin somatropin injection pen. The image depicts a close-up of hands turning the dose dial, emphasizing proper adjustment for subcutaneous injection dosage.*
FDA Label Image

Fig-bb (Fig Bb)

Fig-bb (Fig Bb)
Illustration showing how to remove a cap from a Norditropin injection pen. The image depicts hands gripping the pen and twisting the cap in the direction indicated by an arrow for removal before subcutaneous injection.*
FDA Label Image

Fig-cc (Fig Cc)

Fig-cc (Fig Cc)
An instructional illustration showing a person using their thumb and forefinger to unlock or adjust a blue injector pen device. The diagram includes a curved arrow indicating the rotating or sliding motion needed, part of a sequence for using or preparing the injection device.*
FDA Label Image

Fig-dd (Fig Dd)

Fig-dd (Fig Dd)
An instructional illustration showing how to use the insertion button on a Norditropin injection device. The image highlights a user's hand pressing the insertion button, with the display window visible, demonstrating part of the subcutaneous injection preparation process.*
FDA Label Image

5mg-carton (5mg Carton)

5mg-carton (5mg Carton)
Norditropin FlexPro 5 mg/1.5 mL Prefilled Pen injection label by Novo Nordisk. The packaging shows a single-use prefilled pen for subcutaneous injection containing somatropin. Label includes dosage strength, product image, barcode, and usage instructions.*
FDA Label Image

10mg-carton (10mg Carton)

10mg-carton (10mg Carton)
Norditropin FlexPro 10 mg/1.5 mL Prefilled Pen packaging label shows a subcutaneous injection solution of somatropin. The label includes product imagery of the prefilled pen, dosage strength, route of administration, and details like single-patient use. It is manufactured by Novo Nordisk with visible barcodes and regulatory text.*
FDA Label Image

15mg-carton (15mg Carton)

15mg-carton (15mg Carton)
Norditropin FlexPro 15 mg/1.5 mL prefilled pen injection carton. The label shows somatropin injection for subcutaneous use, containing one 1.5 mL single-patient-use prefilled pen. The labeler is Novo Nordisk. The packaging features images of the green and navy blue pen with dosage indicators and includes NDC 0169-7708-21.*
FDA Label Image

30mg-carton (30mg Carton)

30mg-carton (30mg Carton)
Packaging label for Norditropin FlexPro 30 mg/3 mL Prefilled Pen, a somatropin injection for subcutaneous use. The label shows a purple pen image and states it contains 1 prefilled pen for single-patient use. Labeler is Novo Nordisk. Includes NDC 0169-7703-21 and Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.